- ISIN
- US9418481035
- CUSIP
- 941848103
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Nov 16, 1995
Highlights
- Market Cap
- $29.43B
- Enterprise Value
- $34.18B
- EPS (TTM)
- $6.88
- PE Ratio
- 52.07
- Total Revenue (TTM)
- $3.77B
- Gross Profit (TTM)
- $2.07B
- EBITDA (TTM)
- $924.47M
- Year Range
- $275.05 - $414.15
- Target Price
- $402.57
- ROA (TTM)
- 1.83%
- ROE (TTM)
- 2.94%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
WAT Performance Chart
Waters Corporation (WAT) is down 5.7% since the beginning of the year. At $358 per share, WAT is trading 13.5% below its 52-week high of $414. Investors who bought $1,000 worth of WAT shares 5 years ago would now be looking at an investment worth $1,032.
Loading charts...
Returns By Period
Waters Corporation (WAT) has returned -5.68% so far this year and 4.56% over the past 12 months. Over the last ten years, WAT has returned 10.21% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Waters Corporation
- 1D
- 0.79%
- 1M
- 4.64%
- YTD
- -5.68%
- 6M
- -6.74%
- 1Y
- 4.56%
- 3Y*
- 11.30%
- 5Y*
- 0.64%
- 10Y*
- 10.21%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
WAT Monthly Returns History
Based on dividend-adjusted daily data since Nov 17, 1995, WAT's average daily return is +0.09%, while the average monthly return is +1.73%. At this rate, an investment would double in approximately 3.4 years.
Historically, 58% of months were positive and 42% were negative. The best month was Jan 2000 with a return of +39.4%, while the worst month was Jun 2001 at -44.4%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 6 months.
On a daily basis, WAT closed higher 51% of trading days. The best single day was Jan 25, 2000 with a return of +37.6%, while the worst single day was Jun 19, 2001 at -29.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.40% | -13.85% | -6.76% | 3.84% | 24.04% | -6.60% | -5.68% | ||||||
| 2025 | 12.00% | -9.18% | -2.32% | -5.65% | 0.43% | -0.06% | -17.27% | 4.52% | -0.66% | 16.61% | 15.39% | -5.85% | 2.39% |
| 2024 | -3.50% | 6.20% | 2.02% | -10.22% | -0.05% | -6.08% | 15.91% | 2.99% | 3.91% | -10.22% | 19.07% | -3.57% | 12.68% |
| 2023 | -4.09% | -5.38% | -0.41% | -2.99% | -16.36% | 6.10% | 3.63% | 1.66% | -2.35% | -13.01% | 17.64% | 17.33% | -3.90% |
| 2022 | -14.08% | -1.06% | -2.00% | -2.37% | 8.23% | 0.92% | 9.99% | -17.97% | -9.74% | 11.00% | 15.85% | -1.16% | -8.06% |
| 2021 | 6.97% | 3.48% | 3.76% | 5.52% | 7.46% | 7.25% | 12.79% | 6.21% | -13.70% | 2.87% | -10.74% | 13.57% | 50.59% |
Benchmark Metrics
Waters Corporation has an annualized alpha of 13.98%, beta of 0.87, and R2 of 0.20 versus S&P 500 Index. Calculated based on daily prices since November 17, 1995.
- This stock captured 138.13% of S&P 500 Index gains and 103.80% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.20 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 13.98%
- Beta
- 0.87
- R²
- 0.20
- Upside Capture
- 138.13%
- Downside Capture
- 103.80%
Return for Risk
Risk / Return Rank
WAT ranks 44 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Waters Corporation (WAT) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WAT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.91 | ||
| Sortino ratioReturn per unit of downside risk | -2.32 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.37 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | 0.15 | 2.78 | -2.64 |
| Martin ratioReturn relative to average drawdown | 0.29 | 12.44 | -12.15 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Waters Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Waters Corporation was 80.12%, occurring on Jul 22, 2002. Recovery took 2205 trading sessions.
The current Waters Corporation drawdown is 15.65%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Dot-com crash2000–2002 | -80.12%Jul 2002 | 1y 9mo | 8y 9mo | 10y 6moSep 2000 - Apr 2011 |
2023 bear market2023 | -44.27%Oct 2023 | 2y 1mo | — | 4y 9moSep 2021 - now |
COVID crash2020 | -35.86%Mar 2020 | 11mo 19d | 9mo 18d | 1y 9moApr 2019 - Jan 2021 |
1999 bear market1999 | -35.07%Dec 1999 | 3mo 1d | 1mo 11d | 4mo 12dSep 1999 - Jan 2000 |
1997 bear market1997 | -29.42%Apr 1997 | 6mo 9d | 1mo 16d | 7mo 25dOct 1996 - Jun 1997 |
Drawdown Indicators
| WAT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.12% | -56.78% | -23.34% |
Max Drawdown (1Y)Largest decline over 1 year | -31.32% | -9.10% | -22.22% |
Max Drawdown (3Y)Largest decline over 3 years | -33.45% | -18.90% | -14.55% |
Max Drawdown (5Y)Largest decline over 5 years | -44.27% | -25.43% | -18.84% |
Max Drawdown (10Y)Largest decline over 10 years | -44.27% | -33.92% | -10.35% |
Current DrawdownCurrent decline from peak | -15.65% | -1.80% | -13.85% |
Average DrawdownAverage peak-to-trough decline | -23.96% | -10.71% | -13.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.83% | 2.03% | +13.80% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Waters Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Waters Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for WAT, comparing it with other companies in the Diagnostics & Research industry. Currently, WAT has a P/E ratio of 52.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for WAT relative to other companies in the Diagnostics & Research industry. Currently, WAT has a P/S ratio of 6.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for WAT in comparison with other companies in the Diagnostics & Research industry. Currently, WAT has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with WAT
Add Waters Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with WAT